Income Taxes - Information (Details) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Income Tax Contingency | ||
| Increase in valuation allowance for deferred tax assets | $ 120,000 | $ 76,500 |
| Capitalized research & development | 64,991 | 80,357 |
| Uncertain tax position | $ 0 | $ 0 |
| Income Tax Examination, Description | All of the Company’s tax years will remain open for examination by the federal and state tax authorities to the extent that the Company's tax attributes are utilized in future years to offset income or income taxes. | |
| Federal | ||
| Income Tax Contingency | ||
| Net operating loss carryforwards | $ 921,900 | |
| Operating loss carryforwards without expiration date | 871,400 | |
| Tax credit carryforward amount | 74,100 | |
| State | ||
| Income Tax Contingency | ||
| Net operating loss carryforwards | 861,400 | |
| Operating loss carryforwards without expiration date | 3,200 | |
| Tax credit carryforward amount | $ 10,400 | |